Leerink Partners analyst Mani Foroohar has maintained their bullish stance on MIRM stock, giving a Buy rating yesterday. Mani Foroohar’s ...

Mirum Pharmaceuticals ( (MIRM) ) has released its Q3 earnings. Here is a breakdown of the information Mirum Pharmaceuticals presented to its ...